Johnny Bennett, Associate Vice President and Head of Chemistry at Merck Research Laboratories, will deliver a seminar entitled "Cyclic Dinucleotide STING agonists for Cancer Treatment – Unlocking Therapeutic Potential through Chemistry." Hosted by Paramjit Arora.